Differential cytokine architecture in patients treated with CART19 versus CART22.
Saved in:
| Title: | Differential cytokine architecture in patients treated with CART19 versus CART22. |
|---|---|
| Authors: | Diorio C; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA DIORIOC@chop.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Shraim R; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Thadi A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Frank-Kamenetskii A; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Uppuluri L; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Klinghoffer H; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Martinez Z; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Babu A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Myers RM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Fraietta JA; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Hughes A; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Sussman J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Xu J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., McClory SE; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Mueller K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Perazzelli J; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Vella LA; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Henrickson SE; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Ruella M; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Behrens EM; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., DiNofia AM; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Burkhardt JK; Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA., Maude SL; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Canna S; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Tan K; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Grupp S; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Teachey DT; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA. |
| Source: | Journal for immunotherapy of cancer [J Immunother Cancer] 2026 Jun 19; Vol. 14 (6). Date of Electronic Publication: 2026 Jun 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42320984 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Differential cytokine architecture in patients treated with CART19 versus CART22. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Diorio+C%22">Diorio C</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA DIORIOC@chop.edu.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Shraim+R%22">Shraim R</searchLink>; Division of Oncology and Center for Childhood Cancer Research, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Thadi+A%22">Thadi A</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Frank-Kamenetskii+A%22">Frank-Kamenetskii A</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Uppuluri+L%22">Uppuluri L</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Klinghoffer+H%22">Klinghoffer H</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Martinez+Z%22">Martinez Z</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Babu+A%22">Babu A</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Department of Biomedical and Health Informatics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Myers+RM%22">Myers RM</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Fraietta+JA%22">Fraietta JA</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Hughes+A%22">Hughes A</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Sussman+J%22">Sussman J</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Xu+J%22">Xu J</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22McClory+SE%22">McClory SE</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Mueller+K%22">Mueller K</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Perazzelli+J%22">Perazzelli J</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Vella+LA%22">Vella LA</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Henrickson+SE%22">Henrickson SE</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Ruella+M%22">Ruella M</searchLink>; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Behrens+EM%22">Behrens EM</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22DiNofia+AM%22">DiNofia AM</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Burkhardt+JK%22">Burkhardt JK</searchLink>; Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Maude+SL%22">Maude SL</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Canna+S%22">Canna S</searchLink>; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Tan+K%22">Tan K</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Grupp+S%22">Grupp S</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.<br /><searchLink fieldCode="AU" term="%22Teachey+DT%22">Teachey DT</searchLink>; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2026 Jun 19; Vol. 14 (6). <i>Date of Electronic Publication: </i>2026 Jun 19. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42320984 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/jitc-2026-015126 Languages: – Code: eng Text: English Titles: – TitleFull: Differential cytokine architecture in patients treated with CART19 versus CART22. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Diorio C – PersonEntity: Name: NameFull: Shraim R – PersonEntity: Name: NameFull: Thadi A – PersonEntity: Name: NameFull: Frank-Kamenetskii A – PersonEntity: Name: NameFull: Uppuluri L – PersonEntity: Name: NameFull: Klinghoffer H – PersonEntity: Name: NameFull: Martinez Z – PersonEntity: Name: NameFull: Babu A – PersonEntity: Name: NameFull: Myers RM – PersonEntity: Name: NameFull: Fraietta JA – PersonEntity: Name: NameFull: Hughes A – PersonEntity: Name: NameFull: Sussman J – PersonEntity: Name: NameFull: Xu J – PersonEntity: Name: NameFull: McClory SE – PersonEntity: Name: NameFull: Mueller K – PersonEntity: Name: NameFull: Perazzelli J – PersonEntity: Name: NameFull: Vella LA – PersonEntity: Name: NameFull: Henrickson SE – PersonEntity: Name: NameFull: Ruella M – PersonEntity: Name: NameFull: Behrens EM – PersonEntity: Name: NameFull: DiNofia AM – PersonEntity: Name: NameFull: Burkhardt JK – PersonEntity: Name: NameFull: Maude SL – PersonEntity: Name: NameFull: Canna S – PersonEntity: Name: NameFull: Tan K – PersonEntity: Name: NameFull: Grupp S – PersonEntity: Name: NameFull: Teachey DT IsPartOfRelationships: – BibEntity: Dates: – D: 19 M: 06 Text: 2026 Jun 19 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2051-1426 Numbering: – Type: volume Value: 14 – Type: issue Value: 6 Titles: – TitleFull: Journal for immunotherapy of cancer Type: main |
| ResultId | 1 |